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Background: The mechanisms underlying acute ERK signaling are poorly understood.
Results: Feedback influences basal and acutely stimulated ERK responses but does not render signaling kinetics robust to ERK
concentration.
Conclusion: Acute ERK response kinetics depend on ERK concentration and activation mechanism as well as feedback.
Significance: ERK responses to transient stimulation can be gated by ERK concentration, and short-term activation appears
distributive rather than processive.
Many extracellular signals act via the Raf/MEK/ERK cascade
in which kinetics, cell-cell variability, and sensitivity of the ERK
response can all influence cell fate. Here we used automated
microscopy to explore the effects of ERK-mediated negative
feedback on these attributes in cells expressing endogenous
ERK or ERK2-GFP reporters. We studied acute rather than
chronic stimulation with either epidermal growth factor (ErbB1
activation) or phorbol 12,13-dibutyrate (PKC activation). In
unstimulated cells, ERK-mediated negative feedback reduced
the population-average and cell-cell variability of the level of
activated ppERK and increased its robustness to changes in ERK
expression. In stimulated cells, negative feedback (evident
between 5min and 4 h) also reduced average levels and variabil-
ity of phosphorylated ERK (ppERK) without altering the “grad-
edness” or sensitivity of the response. Binning cells according to
total ERK expression revealed, strikingly, that maximal ppERK
responses initially occur at submaximal ERK levels and that this
non-monotonic relationship changes to an increasing, mono-
tonic one within 15 min. These phenomena occur in HeLa cells
andMCF7breast cancer cells and in the presence and absence of
ERK-mediated negative feedback. They were best modeled
assuming distributive (rather than processive) activation. Thus,
we have uncovered a novel, time-dependent change in the rela-
tionship between total ERK and ppERK levels that persists with-
out negative feedback. This changemakes acute response kinet-
ics dependent on ERK level and provides a “gating” or control
mechanism in which the interplay between stimulus duration
and the distribution of ERK expression across cells could mod-
ulate the proportion of cells that respond to stimulation.
Many extracellular stimuli control cell fate via mitogen-acti-
vated protein kinase (MAPK) cascades (1–4). The best charac-
terized of these is the Raf/MEK/ERK pathway, in which Raf
kinases phosphorylate and activate MEK (MAPK/ERK kinase)
that in turn phosphorylate ERK1 and ERK2 on Thr and Tyr
residues of a Thr-Glu-Tyr activation loop (1–4). ERK (used
here to denote ERK1 and/or ERK2) is mainly cytoplasmic in
resting cells, but activation causes nuclear accumulation of dual
phosphorylated ERK (ppERK)3 (5, 6), enabling phosphorylation
of substrates that control transcriptional responses and, in turn,
cell fate decisions (7, 8). MAPKmodules show a broad range of
input-output behaviors, reflecting the need for the wide range
ofMAPK stimuli to exert distinct effects onmany cellular activ-
ities (8, 9). For example, stimuli causing sustained ERK activa-
tion and sustained translocation of ppERK to the nucleus can
have different effects on biological outcome than those causing
only transient activation (10–13), and these kinetic differences
can reflect stimulus-specific feedback mechanisms. Indeed,
ERK-mediated negative feedback can influence response kinet-
ics rapidly (within 5–25 min) by inhibitory phosphorylation of
Raf or Son of Sevenless (SOS) protein and more slowly (40
min) by increasing expression of nuclear-inducible dual speci-
ficity phosphatases (14).
In addition to influencing response kinetics, ERK-mediated
feedback can alter system sensitivity to changes in input (i.e.
stimulus concentration) and to changes in system constraints
and parameters (such as concentrations of network compo-
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nents and rate constants for their activation and inactivation) as
well as cell-cell variability, all of which can be important for
effects of ERK on cell fate (15, 16). Here, the “gradedness” of
ERK signaling is of particular importance, as in many systems a
gradual increase in stimulus causes graded responses in indi-
vidual cells over a wide range of stimulus intensity, whereas in
others there is an “ultrasensitive” response where large differ-
ences in output occur over a narrow input range, giving the
appearance of an “all-or-nothing” response. Graded responses
are thought to mediate reversible cellular activities, whereas
all-or-nothing responses can impose a threshold for production
of the binary decisions controlling irreversible processes such
as cell cycle progression (17–22). In individual cells, graded
inputs can drive digital outputs, and this analog-to-digital con-
version can occur at different stages of a pathway. For example,
in Xenopus oocytes increasing concentration of progesterone
causes switch-like activation of ERK (23), whereas in Swiss 3T3
cells increasing EGF concentration causes graded activation of
ERK with consequent switch-like stimulation of early gene
expression and cell cycle progression (18). In this context the
distributive activation of ERK is important; ERK binds MEK
and is thenmonophosphorylated and released before rebinding
to facilitate the second phosphorylation in the Thr-Glu-Tyr
loop (24). This mechanism can result in ultrasensitivity of the
Raf/MEK/ERK cascade (17). Despite this, graded responses are
observed (17), and this may reflect scaffolding or molecular
crowding, which promotes rapid enzyme substrate rebinding
and thereby converts distributive to (pseudo)processive activa-
tion in vivo (25, 26). This is consistent with work on the yeast
MAPK cascade where scaffolding of Ste11, Ste7, and Fus3
(MAPKKK, MAPKK, and MAPK, respectively) by Ste5 pro-
motes graded signaling in response to stimulation with a mat-
ing pheromone (19). In that study the MAPK cascade could
mediate graded or ultrasensitive responses, dependent upon
the type of stimulus used (mating pheromone versus increased
osmolarity). This fundamental feature of a single MAPK cas-
cade mediating these distinct behaviors is also seen in T cells,
where exposure to antigen-presenting cells elicits all-or-noth-
ing ERK activation, whereas chemokine activation can cause
graded responses (20).
The preceding discussion illustrates the richness of ERK sig-
naling, with response kinetics, sensitivity, and cell-cell variabil-
ity all having the potential to influence the consequences of
ERK activation and all being subject to negative feedback. The
importance of this is illustrated by the fact that ERK-mediated
negative feedback dictates responsiveness of cells to inhibition
of upstream kinases (21). However, most work on feedback
control of this system has involved chronic (long term) stimu-
lation, and less is known about its importance for regulation of
the cascade under acute (short term) stimulation. Here, we
have addressed this using automated cell imaging to monitor
ERK phosphorylation and nuclear translocation as well as ERK-
driven transcription in HeLa cells.We stimulated the cells with
EGF to activate ErbB1 receptors or with phorbol 12,13-dibu-
tyrate (PDBu) to activate protein kinase C (PKC). In unstimu-
lated cells we found clear evidence that negative feedback influ-
ences population-averaged ppERK levels, cell-cell variability in
ppERK levels, and system robustness. In stimulated cells nega-
tive feedback between 5min and 4 h of stimulation with EGF or
PDBu influenced variation and mean levels of ppERK, but we
found no evidence for it affecting response sensitivity.
Previous work suggests that negative feedback could make
the signaling system robust to changes in the concentrations of
the proteins in the cascade (21), and we find clear evidence for
this in unstimulated cells.However, whenwe explored relation-
ships between total ERK and ppERK under short term stimula-
tion, we observed maximal ppERK levels at submaximal ERK
expression levels soon after stimulation (at 5 min) and then a
switch to monotonic behavior within 15 min of stimulation.
This occurred in two cell types (HeLa andMCF7 cells) and at a
broad range of EGF concentrations in both the presence and
absence of negative feedback. It could be modeled mathemati-
cally assuming distributive (but not processive) activation. Fur-
thermore, increasing ERK expression levels increased the time
taken to reach themaximal ppERK response, providing amech-
anism for “gating” or control of the ERK response. Thus, in the
non-equilibrium conditions of acute stimulation, there is a
novel time-dependent change in the relationship between ERK
and ppERK levels that persists in the presence of negative feed-
back, is suggestive of distributive activation, and makes acute
ERK response kinetics dependent upon ERK expression levels
in our system.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection—HeLa cells and MCF7 cells
(from European Collection of Cell Cultures) were cultured in
10% FCS-supplemented Dulbecco’s modified Eagle’s medium
(DMEM). For experiments they were harvested by trypsiniza-
tion and seeded at 3–5  103 cells/well in 96-well plates. For
some experiments ERKwas knocked down by reverse transfec-
tion using RNAiMAX (Invitrogen) and two siRNA duplexes
(Qiagen, Crawley, UK) each for ERK1 and ERK2 (27, 28). A
mixture of all four ERK duplexes or control siRNA against GFP
(Ambion, Warrington, UK) was used (at 2.5 nM total). Where
ERK was knocked down, recombinant adenovirus (Ad) were
used to add back previously characterized (29) imaging report-
ers consisting of wild-type (WT) ERK2 in tandem with green
fluorescent protein (ERK2-GFP) or a catalytically inactive
mutant (K52R ERK2-GFP). Cells were transduced with Ad
ERK2-GFP in DMEM with 2% FCS 16 h after siRNA transfec-
tion. The Ad-containingmediumwas removed after 4–6 h and
replaced with fresh DMEM with 0.1% FCS. For some experi-
ments cells were transduced with Ad for an Egr-1 promoter
driving expression of dsRED or zsGREEN. Ad5 zsGREEN and
DsRedExpress vectors weremade by digesting pzsGREEN1-DR
and pDsRed-Express-DR (Clontech) with BamHI/NotI and
subcloning fluorescent protein cDNAs into a corresponding
digest of promoterless pAd5K-NpA vector (a gift from Prof.
Beverly Davison, Gene Transfer Vector Core, University of
Iowa). Egr-1 promoterwas amplified using 5-tat gta ctc gag acg
gag gga ata gcc ttt cg-3 forward primer and 5-tat gta gaa ttc gag
aac tga tgt tgg gtg gtg-3 reverse primer using Egr-1-promoter-
Luc vector (30) as template. The product was digested with
XhoI and EcoRI (underlined) and subcloned into the corre-
sponding digests of pAd5 zsGREEN1-DR and pAd5 DsRed-
Express-DR. All Ad were generated from shuttle vectors as
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described (31) and were added to cells at the same time using
0.5–10 plaque-forming units (pfu)/nl. In the HeLa cell sys-
tem used here this yields multiplicity of infection values of
10–100 and transduction efficiency approaching 100%. The
cells were cultured for 16–24 h after transduction and were
then stimulated with EGF or PDBu (Sigma) as outlined in the
legends to Figs. 1 and 3–7. For some experiments the cells
were also treated with a selective ERK inhibitor, FR180204
(Tocris Bioscience, Bristol, UK), or the structurally related
negative control compound, 328008 (Calbiochem) as out-
lined in the figure legends.
High-content Image Acquisition and Analysis—Cells were
cultured, plated, transfected, and transduced on Costar black-
wall 96-well plates (Corning, Arlington, UK) as described (27,
29). After stimulation they were fixed in 4% paraformaldehyde
(in PBS) and permeabilized in20 °Cmethanol. Inmost exper-
iments cells were stained for ppERK by blocking in 5% normal
goat serum, PBS and probing with mouse anti-ppERK mono-
clonal antibody (MAPK-YT, 1:200, Sigma) in PBS and visual-
ization with Alexa 488- or 546-conjugated goat anti-mouse
antibodies (1:200 Invitrogen). Total ERK was stained with rab-
bit anti-ERK monoclonal (137F5, 1:100, Cell Signaling Tech-
nology, Hutchin, UK) and Alexa 546-conjugated goat anti-rab-
bit antibody (1:200, Invitrogen). Nuclei were also stained (600
nMDAPI in PBS), and formost experiments the fluorescence of
ERK2-GFP, dsRED and/or zsGREENwas also visualized. Image
acquisition was automated using an IN Cell Analyzer 1000 (GE
Healthcare) microscope as described (32, 33) with a10 objec-
tive and excitation and emission filters of 360 and 460 nm for
DAPI, 475 and 535 nm for Alexa 488, GFP, and zsGREEN, or
535 and 620 nm for Alexa 546 and dsRED. Representative dig-
ital images are shown in Fig. 1. Automated image analysis algo-
rithms were used to define perimeters and fluorescence inten-
sity within regions of interest (nucleus and cytoplasm or
nucleus and nuclear collar). The multi-target analysis algo-
rithm in the IN Cell Analyzer Work station was used to define
nuclear perimeters from the DAPI stain. For cells without
ERK2-GFP the fluorophores imaged could not be used as cell
masks (because of low fluorescence in unstimulated cells) so we
expanded the nuclear perimeter (3 m collar) to capture cyto-
plasmic fluorescence. Whole cell (nucleus plus cytoplasm)
fluorescence measures were used for ERK, ppERK, ERK2,
ppERK2, dsRED, and zsGREEN and are reported in arbitrary
fluorescence units (AFU). In some experiments the propor-
tion of ERK2-GFP in the nucleus was calculated. For most
experiments, replicate treatments were applied in 2–4 wells
and 4–9 fields of view were collected per well, yielding data
for 10,000 individual imaged cells (for each treatment in
each experiment). This was used to produce population-av-
eraged mean responses and for frequency distributions of
individual cell measures (29) or was transformed and binned
as described in the figure legends. Log concentration-re-
sponse relationships were fitted (GraphPad Prism, La Jolla,
CA) to Sigmoid curves of variable slope to estimate EC50
values and Hill coefficients.
Models and Modeling—The mathematical models were
based on mass action kinetics using ordinary differential
equations of the core ERK activation pathway mechanism.
Two computational models, Processive and Distributive,
were employed to investigate transient activation of ERK
for different total ERK levels. Details are given in the supple-
mental data.
RESULTS
Negative Feedback Control of ERK Signaling—The Raf/MEK/
ERK module is subject to rapid (transcription-independent)
negative feedback by mechanisms including ERK-mediated
phosphorylation of Raf and to slower (transcription-depend-
ent) feedback by mechanisms including ERK-mediated induc-
tion of dual specificity phosphatases. In addition, different
inputs to Raf (such as active ErbB1 or PKC) may have stim-
ulus-specific upstream adaptive mechanisms. Such feedback
has the potential to influence not only response kinetics but
also cell-cell variability and response sensitivity and to do so
in a time-dependent and stimulus-specific manner. Here we
used automated microscopy (Fig. 1, A and B) to explore how
ERK-mediated negative feedback influences ERK signaling
in HeLa cells stimulated with EGF (ErbB1 activation) and
PDBu (PKC activation). Anticipating that negative feedback
could underlie desensitization we tested for this by monitor-
ing the time-dependent effect of stimulation on ppERK
levels.
As expected (27, 29), EGF and PDBu both caused rapid and
transient ERK activation, increasing ppERK to the maxima at
5–15 min (Fig. 1C). These responses were initially comparable
but were then more sustained with PDBu than with EGF. For
some experiments we used siRNA to knock down endogenous
ERK and recombinant Ad to add back ERK2-GFP. With this
protocol, knockdown efficiency is90%, and the reporter mir-
rors endogenous ERK activity (27, 29, 34). This again revealed
more sustained elevation of ppERKwith PDBu (not shown) and
that both stimuli increased the proportion of ERK2 in the
nucleus, effects that were againmore sustainedwith PDBu (Fig.
1D). We also used these protocols to construct concentration-
response curves at 5 min and 4 h. This revealed concentration-
dependent increases in ppERKwith responses lower at 4 h than
at 5 min (Fig. 1, F and G). Curve-fitting revealed a time-depen-
dent reduction in EGF potency, with EC50 values of 2 pM at 5
min and 15 pM at 4 h. The EC50 for PDBu (2.6 nM) and the Hill
coefficients for EGF and PDBu (1.4 and 0.5, respectively) at 5
min were indistinguishable from those at 4 h (p  0.1). For
some experiments we also transduced cells with Ad Egr-1
zsGREEN or Ad Egr-1 dsRED as transcriptional readouts for
ERK activation. Both stimuli caused increased zsGREEN (Fig. 1,
E andH) from 1 to 2 h, with near linear accumulation from 2 to
6 h. Similar datawere obtained after knockdown of endogenous
ERKand add-back of ERK2-GFPwith the Egr-1 dsRED reporter
(not shown), and both responses were abolished by co-incuba-
tion with theMEK inhibitor PD184352 (10M), demonstrating
MEK/ERK dependence (not shown). For each reporter, the
PDBu effect was greater than that of EGF (Fig. 1, E and H, and
data not shown). Together, these data confirm earlier work (27,
29, 33) showing that these ERK activation and translocation
responses are more-or-less transient (Fig. 1, C and D) and that
response kinetics typically differ for the two stimuli used. The
data indicate the occurrence of negative feedback and suggest
ERK Expression Level and Feedback Dictate Response Kinetics
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that some of its mechanisms are stimulus-specific. They also
extend earlier work by showing that adaptation influences
stimulus potency (Fig. 1, F and G) but not sensitivity (as mea-
sured by Hill coefficients at 5 min and 4 h). Moreover, they
reveal that the transcriptional effect of PDBu is greater than
that of EGF (Fig. 1, E and H), which most likely reflects the
ability of PDBu to cause a more sustained phosphorylation and
nuclear translocation of ERK (Fig. 1, C and D).
FIGURE1.TimeandconcentrationdependenceofEGFandPDBueffectsonERK inHeLacells as revealedbysemi-automated fluorescencemicroscopy.
The toppanelsaredigital images illustrating the typeof rawdataused for this study.Panel A shows cells transfectedwith siRNA targetingendogenousERK1and
ERK2, transduced with Ad ERK2-GFP, then stimulated for 5 min with or without EGF (10 nM) or PDBu (1 M) before being fixed, stained, and imaged for DAPI
(nuclei) and ERK2-GFP as well as ppERK2. Panel B shows cells transducedwith Ad Egr1-dsRED and stimulated for 4 hwith or without EGF or PDBu before being
fixed, stained with DAPI, and imaged for DAPI, endogenous ppERK, and dsRED. Digital images were acquired for each fluorophore using a 10 objective and
6–10 fields of viewperwell, and automated imageanalysiswas thenused todefineperimeters of nuclei and cells and fluorescence intensitywithin these areas,
as described under “Experimental Procedures.” Each panel has awidth of170mand, therefore, shows5%of the field captured. These are representative
images (from the experiments used for panels C–H) illustrating the ability of EGF and PDBu to increase the proportion of ERK within the nucleus (arrows) and
Egr1-driven transcription as well as whole cell ppERK levels. Panels C and D are time-courses from cells with endogenous ERK (C) or after siRNA-mediated
knockdown of ERK and Ad-mediated add-back of ERK2-GFP (D) that were incubated from t 0 with EGF (10 nM, filled triangles) or PDBu (1 M, filled circles) or
control medium (Ctrl., open circles). Panels F and G are from cells with endogenous ERK that were stimulated 5min or 4 h with the indicated concentrations of
EGForPDBu.Panels EandHare fromcells transducedwithAdEgr1-zsGREENandstimulatedas shown.Cellswere fixed, stained, imaged, andanalyzedas above.
The data are whole cell measures except for D, where the proportion of ERK2-GFP in the nucleus is shown. Data shown are population averages from 2–5
experiments (mean S.E., n 2–5) and are in AFUor are normalized tomaximal responses to PDBu (in each of the repeated experiments). Data obtainedwith
the Egr1-dsRED reporter (B) are qualitatively similar to those with the Egr1-zsGREEN reporter (E and H).
ERK Expression Level and Feedback Dictate Response Kinetics
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Negative feedback can influence cell-cell variability irrespec-
tive of whether the average response is graded or all-or-noth-
ing. In the first instance we explored this for unstimulated cells
where frequency-distribution curves revealed single log ERK
and log ppERK peaks and near-Gaussian distribution (not
shown). We might expect greater variation of ppERK than of
total ERK (due to additional variance in the proportion that is
phosphorylated), but the opposite was observed as coefficients
of variation (CVs) calculated for single cell measures were
higher for ERK (0.030) than for ppERK (0.025), implying that
negative feedback restricts variability in ppERK levels. We also
used the ERK knockdown/add-back protocol and found that
cell-cell variability in ppERK2 levels was again lower than that
for ERK2 (compare the spread for the open circles in Fig. 2, A
and B, or in D and E, and see the Fig. 2 legend for CVs). This
protocol enables use of mutant reporters (27, 29) so we per-
formed the same experiment using Ad expressing catalytically
inactive K52R ERK2 (again as a GFP chimera). Frequency-dis-
tribution plots for wild-type ERK2 and K52R ERK2 were indis-
tinguishable (Fig. 2A, open and filled circles) with CVs of0.04,
whereas the corresponding plots for ppERK2 revealed lower
variability for ERK2 than for K52R ERK2 (Fig. 2B, open and
filled circles, for which CVs were 0.028 and 0.05, respectively).
Thus, negative feedback mediated by catalytic activity of ERK
reduces cell-cell variability in ppERK levels in the face of varia-
bility in total ERK levels for unstimulated HeLa cells.
In the experiments above Ad ERK2-GFPwas used at 1 pfu/nl
to give ERK2 levels close to that of endogenous ERK, butwe also
performed similar experiments using the Ad at 10 pfu/nl. This
caused the expected increase in population-averaged ERK2
expression (4-fold) and also increased ERK2 cell-cell variabil-
ity (CVs were 0.04 and 0.12 with 1 and 10 pfu/nl, respec-
tively). This increase in ERK2 variability was associated with
increased variation for dual phosphorylation of K52R ERK2
(CVs 0.049 and 0.096, respectively) but not of WT ERK2 (CVs
0.028 and 0.030, respectively), confirming the effect of negative
feedback above. The protocol also provides a broad range of
ERK2 levels for exploration of relationships between total ERK2
and the system response. Binning the data obtained with both
Ad titers according to ERK2 levels and plotting this against
ppERK2 revealed a near linear increase in ppERK2 as K52R
ERK2 increased to 1000 AFU (Fig. 2C), whereas no such
increase was seen in cells expressing wild-type ERK2.
As a complementary approach we used a competitive inhib-
itor of ERK, FR180204, that prevents its catalytic activity but
not its Thr-Glu-Tyr phosphorylation (35). In preliminary
experiments we used 1MPDBu to activate an Egr-1-luciferase
reporter and found near maximal inhibition (90%) of this
FIGURE2. InunstimulatedHeLacells ERK-mediated feedback reduces cell-cell variability inppERKand increases systemrobustness to changes inERK
expression levels. Panels A and B showdata fromexperiments using siRNA to knock down endogenous ERK andAd to add-back ERK2-GFP or K52R ERK2-GFP.
Ads were used at 1 pfu/nl. The data are frequency-distribution plots of log ppERK2 or ERK2-GFP (in AFU) from single representative experiments each with
10,000 cells per plot and cells expressing either ERK2-GFP (open circles) or K52R ERK2-GFP (filled circles). Similar experiments were also undertaken with a
higher Ad titer (10 pfu/nl), and pooling data from three such experiments revealed that CVs for ERK2-GFP expression were greater than those for ppERK2 (i.e.
0.038 0.004 and 0.026 0.002 at 1 pfu/nl) and that increasing the Ad ERK2-GFP increased cell-cell variability in ERK2-GFP (CVs 0.038 0.004 and 0.104
0.003 at 1 and 10 pfu/nl, respectively, p  0.05) but did not increase variability for ppERK2-GFP (CVs 0.026  0.002 and 0.028  0.001 at 1 and 10 pfu/nl
respectively, p 0.1). CVs for ERK2-GFP did not differ between cells expressing WT- or K52R-ERK2-GFP (at either titer, p 0.1), whereas the K52R mutation
increased cell-cell variability in ppERK2-GFPmeasures at both titers (CVs increased from0.026 0.002 to 0.049 0.003 at 1 pfu/nl (p 0.05) and from0.028
0.001 to 0.098 0.002 at 10 pfu/nl (p 0.05)). Panel Cwas generated by binning individual cells according to their ERK2-GFP expression level and calculating
themean ppERK2 level in each bin. The bins had ranges of 100–200, 200–400, 400–800, 800–1600, and 1600–3200 AFU (machine backgroundwas typically
100–140AFU so values below100were not obtained), and thedatawere pooled from3 separate experiments (mean S.E.,n 3) similar to the one illustrated
in panels A and B. Panels D and E are froma similar experiment except that all cells receivedAd ERK2-GFP, and theywere also pretreated for 1 or 24 hwith 30M
ERK inhibitor FR180204 (FR) or with control medium (Ctrl.) as indicated before fixing, staining (for ppERK2), and imaging. The data shown are frequency
distribution plots for single cell measures of ERK2 (D) and ppERK2 (E) in unstimulated cells, and the data are from a single representative experiment with the
higher Ad titer. Panel Fwas generated by binning individual cells from both Ad titers (1 and 10 pfu/nl) according to their ERK2-GFP expression level as above.
The data were pooled from three separate experiments (mean S.E., n 3) similar to the one illustrated in panels D and E. In addition data are shown for cells
pretreated for 24 h with 30 M compound 328008, a structurally related negative control compound (ve) that does not inhibit ERK.
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ERK-mediated response with 30 M FR180204 (data not
shown; see Ref. 29 for methods). We then used the ERK knock-
down/add-back protocol above, treating unstimulated cells for
1 or 24 h with 30 M FR180204 before imaging for ERK2 and
ppERK2. The inhibitor did not measurably influence popula-
tion average ERK2 levels but increased average ppERK2 from
192  7 to 236  8 AFU (mean  S.E., n  3, p  0.05).
Frequency distribution plots (Fig. 2, D and E) revealed that
FR180204 increased cell-cell variability of ppERK2 levels but
not ERK2 levels (as illustrated by the increasing spread of the
distributions in Fig. 2E but not in 2D). We also treated cells for
24 hwith a structurally related negative control compound that
does not inhibit ERK (328008) and again exploited the broad
range of ERK2 levels to define relationships between total ERK2
and ppERK2. Data binning revealed little or no increase in
ppERK2 with increasing levels of ERK2 in control cells or in
cells treated with the negative control compound (Fig. 2F).
In contrast, increasing ERK2 was associated with marked
increases in ppERK2 in cells exposed for 1 or 24 h to FR180204.
The data obtained with chemical inhibition (Fig. 2, D–F) are
thus similar to those obtained with the catalytically inactive
ERK2mutant (Fig. 2,A–C). Together, they confirmearlierwork
showing that ERK activity is required for negative feedback
control of population-averaged ppERK values (29) and, more-
over, go on to show that in unstimulated cells, such feedback
also controls cell-cell variability in ppERK levels and increases
system robustness to changes in ERK levels.
The fact that that ERK-mediated negative feedback reduces
population-averaged ppERK levels in unstimulated cells (Fig. 2)
raises the question of whether it also underlies desensitization
of ppERK responses in stimulated cells (Fig. 1). To test this, we
used the ERK knockdown/add-back protocol, constructing
concentration-response curves for EGF at 5 min and 4 h. This
revealed clear concentration-dependent increases in ppERK2,
and the desensitization was less pronounced in cells with cat-
alytically inactive K52R ERK2 (Fig. 3, A and B). Physiological
EGF concentrations are estimated to be between 0.1 and 10 nM
(36), and for each of these concentrations the reduction in
ppERK2 occurring between 5 min and 4 h was at least 2-fold
higher in cells with ERK2 than in cells with K52R ERK2 (Fig. 3,
A and B). Similar data were obtained in PDBu-stimulated cells
(not shown).
These data support a role for ERK-mediated feedback that
could be dependent or independent of transcription. To test for
the latter we used acute stimulation (2–14 min), and this
revealed rapid increases in ppERK with EGF and PDBu in cells
with ERK2. The response to EGF was more transient (than that
to PDBu) and, importantly, wasmore sustained in cells express-
ing K52R ERK2 (Fig. 3, C and D). Similar experiments were
performed with the ERK inhibitor FR180204, and these
revealed similar results. Again, the response to EGF was more
transient than that to PDBu (in the absence of the inhibitor) but
was sustained after 24 h of pretreatment with FR180204 (Fig. 3,
E and F). Interestingly, the response to EGF was also more sus-
tained after only 1 h of pretreatment with FR180204 (i.e. the
effects of 1 and 24 h FR180204 treatment on response kinetics
were indistinguishable; not shown), whereas the effect of
FR180204 on the ERK2-ppERK2 relationship was more pro-
nounced at 24 h than at 1 h (Fig. 2F). Presumably the FR180204
effect on basal ppERK develops slowly because ERK activity is
low in unstimulated cells rather than because FR180204-medi-
FIGURE 3. In stimulated HeLa cells ERK-mediated feedback influences the
kinetics of EGF effects on population average ppERK responses and also
cell-cell variability in ppERK levels. Panels A and B, cells were cultured and
transfected with siRNA targeting endogenous ERK1 and ERK2 and transduced
with Ad ERK2-GFP or Ad K52R ERK2-GFP before stimulation with EGF for 5 min
(filled circles) or 4 h (open circles) and then stained and imaged (for DAPI and
ppERK2). The data are population average ppERK2 levels (mean S.E. n 2–6).
Foreachof theseexperimentswealsocalculatedCVs for thesinglecellmeasures,
and pooling these revealed that the concentration-dependent effects of EGF on
population-averagedppERKvalueswereparalleledby theeffectsoncell-cell var-
iability. CV values for ERK2-GFP-expressing cells treated for 5 min with 0, 1014,
1013, 1012, 1011, 1010, 109, and107 M EGFwere 0.022, 0.019, 0.024, 0.025,
0.041,0.058,0.070,and0.067, respectively, andthiseffectwas lesspronounced in
cells stimulated for4hwithEGF (CVvalues0.023,0.027,0.023,0.020,0.019,0.025,
0.032, and 0.036 respectively, over the same EGF concentrations). The effect of 5
min of treatment with EGF was also less pronounced in cells expressing K52R-
ERK2 (CV values 0.041, 0.050, 0.056, 0.055, 0.059, 0.063, 0.065, and 0.068 for the
same EGF concentrations in K52R ERK2-expressing cells), and the mutation did
not prevent the time-dependent reduction in effect of EGF on CVs (CV values
0.041, 0.041, 0.041, 0.041, 0.044, 0.046, 0.049, and0.057 for the sameEGFconcen-
trationsat4h inK52RERK2-expressingcells).PanelsCandD, cellswere treatedas
above except that they were transduced with ERK2-GFP (open circles) or K52R
ERK2-GFP (filled circles) andwere stimulated for 0–14minwith 10nMEGF (C) or 1
M PDBu (D). Population-averaged ppERK2 values are shown (mean S.E., n
6). Panels E and F show population-averaged ppERK2 levels in cells expressing
ERK2-GFP and stimulated for the indicated periods using 10 nM EGF (E) or 1 M
PDBu (F). The cells hadbeenpretreated for 24hwithmediumcontaining 0 (Ctrl.)
or 30M FR180204 to inhibit ERK as indicated (mean S.E., n 3).
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ated inhibition of ERK is slow. Together these data reveal that
ERK-mediated negative feedback affects population-averaged
ppERK responses under short term stimulation conditions
(within 10 min with EGF; Fig. 3) and also contributes to the
desensitization occurring between 5 min and 4 h (Fig. 3).
The observation that ERK-mediated feedback influences
cell-cell variability in unstimulated cells (Fig. 2) raises the ques-
tion of whether this is also the case in stimulated cells. To assess
this, we constructed frequency-response curves for the single
cell measures corresponding to the population-averaged data
in Fig. 1 and 3. We suspected that different stimuli might yield
all-or-nothing and graded responses and that ERK-mediated
negative feedback might alter such behavior, but we found no
evidence for this. Indeed, each of themeasures (log transformed
levels of ppERK or ppERK2, proportion of ERK2 within the
nucleus, and levels of Egr-1 zsGREEN or dsRED) showed near
Gaussian distributions, and the concentration-dependent
effects of EGF and PDBu on these outputs were always graded
(Fig. 4). Treatments caused the distributions to shift along the
horizontal axes rather than redistributing to or from distinct
responsive and unresponsive subpopulations irrespective of
whether the cells expressed endogenous ERK or were trans-
duced with wild-type or K52R ERK2 (Fig. 4 and data not
shown). Nevertheless, we did observe the effects of stimulation
on cell-cell variability, as evidenced by increased spread of fre-
quency-response curves and associated increases in CVs with
each of the stimuli and each experimental measure. Notably,
the concentration-dependent increase in log ppERK2 caused by
5 min with EGF (Fig. 3A) was paralleled by a concentration-de-
pendent increase in CVs for log ppERK2 (see the legend to Fig.
3). Here, it is important to recognize that the variation is nor-
malized to the mean response (i.e. cell-cell variability is
FIGURE4.Frequency-distributionplots revealunimodaldistributions irrespectiveof the stimulusused, stimulusduration, stimulus concentration,or
end pointmeasured. Panels A–F, plots were generated from the single cell data of the time-course experiments shown in Fig. 1, C–E. Frequency-distribution
plots are shown for log-transformed ppERK (in AFU, panel A and D), % nuclear ERK2-GFP (panel B and E) or zsGREEN (in AFU, panel C and F) in cells stimulated
for variedperiodswith EGF (A–C) or PDBu (D–F). The legend shows stimulus duration inminutes; in each case the legends in the top row apply also to thepanels
in the second row, and several time points are omitted for clarity. The cells for panels A and D contained endogenous ERK1 and ERK2, whereas those for panel
B and Ewere transfectedwith siRNA targetingendogenous ERK1andERK2and transducedwithAdERK2-GFP so that theproportionof ERK2-GFP in thenucleus
could be calculated. Panels G–L, plots were generated from the single cell data acquired in the concentration dependence experiments in Fig. 1. The figure
shows frequency-distributionplots for log transformedppERKor dsRED in cells stimulated for 5minor 4 h as indicatedwith EGFor PDBu. The legends show log
Mconcentration (black lines are for control cellswithout stimulus). The legends forG apply also toH and I, and thoseon J apply also toK and L. All cells contained
endogenous ERK1 and ERK2. Note that the dsRED values are lower than those for zsGREEN, as the latter is more efficiently imaged, and that the unstimulated
values for these reporters differ becausemachine background values (100–150AFU)were subtracted from the data inC and Fbut not from those in I and L. For
all panels, the plots are each derived from1000 cells and are from a single representative experiment.
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increased by stimulation rather than simply scaling with the
mean response). Moreover, this effect was much less pro-
nounced in cells stimulated for 4 h (see the legend to Fig. 3).
Similar data were obtained in PDBu-stimulated cells (not
shown). Similar analysis for cells stimulated up to 14 min with
EGF or PDBu (Fig. 3, C and D) revealed that the effects of both
stimuli on the CVs of ppERK2 were evident at 2 min and max-
imal at 6–8min, although nomeasurable reduction in ppERK2
CVs occurred between 6 and 14min irrespective of whether the
cells expressed ERK2 or K52R ERK2 (not shown).
The simplest interpretation of these data is that ERK-medi-
ated negative feedback reduces cell-cell variability in ppERK
levels under the equilibrium condition of unstimulated cells
(Fig. 2) and that this effect is lost when the equilibrium is per-
turbed by acute stimulation (2–14 min) but becomes re-estab-
lished due to negative feedback developing between 14min and
4 h. Moreover, this negative feedback is ERK-mediated, as the
reduction in ppERK2CVs occurring between 5min and 4 hwas
much greater in cells expressing WT ERK2 than in cells
expressing K52R ERK2 (see the legend to Fig. 3).
Total ERK Concentration and Response Kinetics—The dem-
onstration that ERK-mediated feedback influences system
robustness to changes in ERK concentration in unstimulated
cells (Fig. 2) raises the question of whether it also does so after
stimulation. In a recent study (16) siRNA knockdown of ERK 1
and/or 2 was used to explore relationships between ERK and
ppERK levels (in steady-state conditions of chronic stimula-
tion). It was argued that these measures would be directly pro-
portional without robustness and shown that ERK-mediated
negative feedback conferred partial robustness on the system,
as indicated by a saturating (near hyperbolic) relationship
between ERK and ppERK levels.
We exploited the broad range of ERK2 levels in our Ad
ERK2-GFP add-back protocol (Fig. 2) by sorting the data from
individual cells into bins according to ERK2 expression level
and plotting the mean ppERK level per bin (Fig. 5). From the
earlier study (16) we anticipated that ERK and average ppERK
levels might initially be directly proportional and that this rela-
tionshipmight be lost with the time-dependent development of
ERK-mediated negative feedback, but this was not the case.
Remarkably, the relationship between ERK and ppERK levels
was initially bell-shaped (5min after stimulation) withmaximal
ppERK2 levels obtained at submaximal ERK2 levels using max-
imally effective concentrations of EGF or PDBu (Fig. 5, A and
C). In contrast, monotonic relationships (with maximal
ppERK2 at maximal ERK2 levels) were seen for both stimuli at
15min (Fig. 5,B andD) and thereafter (0.5, 1, 2, and 4h; data not
shown). The implication that ppERK response kinetics are
dependent upon ERK concentrationwas tested by assessing the
time-course for acute activation inHeLa cells binned according
to ERK2-GFP expression level. As shown (Fig. 6,A–D), increas-
ing ERK2 expression not only increased maximal responses to
EGF and PDBu but also slowed the responses. The latter ismost
obvious with data normalized according to the maximum
response for each ERK2 bin (Fig. 6, B andD). The time required
to reach the half-maximal response increased (from1.68 0.37
to 6.24 0.29min in EGF-stimulated cells and from2.65 0.23
to 7.75  0.30 min in PDBu-stimulated cells) as ERK2 levels
increased from bins of 125–250 to 1500–2500 AFU. Most
importantly, however, the bell-shaped relationship between
ERK2 and ppERK2 levels was again seen at early time points
with maximal ppERK2 levels at submaximal ERK2 levels (bins
of 250–500 and 750–1000 AFU for EGF and PDBu at 2 min),
whereas the relationships were again monotonic at later time
points (maximal ppERK2 at maximal ERK2 levels occurred at
12 min for both stimuli). Log ppERK2 frequency-distribution
plots were also generated (data not binned according to ERK2),
and these were unimodal irrespective of the time point (2 or 12
min) or stimulus used (not shown). Similarly, when EGF dose-
response curves were constructed at 2 and 12 min, log ppERK2
frequency-distribution plots were unimodal and responses
were graded with all concentrations (0 or 1012 to 107 M EGF)
at both times (data not shown).
We were interested to know whether the dependence of
ppERK response kinetics on ERK levels was a specific feature of
HeLa cells and, therefore, performed similar experiments in
MCF7 breast cancer cells. Again, we used the ERK knockdown/
add-back protocol, stimulated cells for up to 14 min with EGF
or PDBu, and quantified ERK2 and ppERK2 levels in individual
cells before binning according to ERK2 level. The data obtained
were qualitatively very similar to those with HeLa cells in that
responses were not only greater at higher ERK2 levels (Fig. 6, E
andG) but were also slower at higher ERK levels, as seen in data
normalized to the internal control maximal response in any
given ERK2 bin (Fig. 6, F andH). As with the HeLa cell data, the
time required to reach the half-maximal response increased
FIGURE5.BinningHeLa cells according toERK2expression level reveals a
time-dependent switch from a bell-shaped to a monotonic ERK2-
ppERK2 relationship. Cells were transfected with siRNA targeting endoge-
nous ERK1 and ERK2 and transduced with Ad ERK2-GFP before treatment for
5 or 15min with 10 nM EGF (panels A and B, filled circles) or 1M PDBu (panels
C andD, filled triangles) or without stimulus (Ctrl., open circles). Individual cells
were binned according to ERK2-GFP expression, andmean ppERK2 level was
calculated for each bin. The figures show ppERK2 levels plotted against bin
center and are pooled from three experiments (mean S.E., n 3).
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with increasing ERK2 levels inMCF7 cells (from 2.05 0.05 to
3.53 0.11minwith EGF at 125–250 and 1000–1500AFU and
from 3.55 0.16 to 5.90 0.22 with PDBu and the same ERK2
bins). Moreover, the relationship between ERK2 level and
ppERK2 levels was bell-shaped at 2–4min (maximal responses
in ERK2 bins of 250–500 or 500–750 AFU for both stimuli and
both cell types) and had switched to an increasing monotonic
relationship (maximal responses in the highest ERK2 bin) by 12
min for both stimuli and both cell types (not shown).
Early biochemical studies showed that the activating dual
phosphorylation of ERK is distributive (24). However, its acti-
vation in intact cellsmay be (pseudo)processive due to scaffold-
ing or molecular crowding (26).We usedmathematical model-
ing to address whether our data could best be explained by
distributive or processive activation. We considered two dis-
tinct descriptions of the ERK activation pathway, both based on
the law of mass action, but applied to either processive or dis-
tributive double phosphorylation (for ERK activation) based on
Markevich et al. (17). We used gradient-based minimization
procedures implemented in MATLAB (Mathworks, Natick,
MA) to fit the twomodels to the HeLa cell experimental data at
medium ERK concentrations (for an example see Fig. 7B with
ERK at 750–1000AFU). This allowed estimation of parameters
and initial conditions for the twomodels using the same exper-
imental data points (details in the supplemental data). Having
calibrated the models we then varied only the total ERK con-
centration to simulate low, intermediate, and high ERK levels.
The two models predict markedly different responses (Fig. 7).
The processive activation model predicts that increasing ERK
concentration will simply increase the ppERK response ampli-
tude (Fig. 7A), whereas the distributive model predicts that
increasing ERK concentration will also slow response onset
(Fig. 7B). Both models predict a monotonic relationship
between ERK concentration and ppERK level at later time
points (12 and 14 min), whereas only the distributive model
predicts an initial non-monotonic relationship with maximal
activation at sub-maximal ERK concentration (Fig. 7, A and B).
The key finding of themathematicalmodeling is that only the
distributive model accurately mirrors the wet laboratory data
by predicting dependence of response kinetics on ERK concen-
tration and a switch in the relationship between ERK and
ppERK (fromnon-monotonic tomonotonic) during the first 15
min of stimulation. Themodel predicted that this switch would
occur at a range of inputs. When input intensity was varied (by
setting the active MEK to 2.5, 25, 50, or 100 arbitrary units) the
model predicted bell-shaped ERK-ppERK relationships at 2
min and monotonic relationships at 12 min (not shown). We
tested this experimentally by constructing EGF concentration-
response curves at 2 min and at 12 min in HeLa cells. For each
EGF concentration and time point, data were binned according
to ERK2 level, and non-monotonic ERK2-ppERK2 relation-
ships were seen at 2 min (but not at 12 min) for EGF concen-
trations from1012 to 107 M (Fig. 7,C andD). Importantly, the
distributive model predicts occurrence of the switch in the
absence of ERK-mediated negative feedback, so we tested for
this by repeating the experiments in Fig. 6 using K52R ERK2-
GFP. As expected, EGF rapidly increased ppERK2 levels in cells
expressing ERK2-GFP, with the effects being slower in onset at
higher ERK2-GFP levels (Fig. 7E). EGF also increased ppERK2
levels in cells expressing K52R ERK2-GFP, and again the
responses were slower in onset in cell bins expressing higher
levels of ERK2-GFP (Fig. 7F). Similar data were obtained in
PDBu-stimulated cells, and as above therewas a switchwith the
relationship between ERK2-GFP and ppERK level being non-
monotonic at 2 min (maximal responses in 250–500 or 500–
750 ERK2 bins) butmonotonic at 12min (maximal responses in
1000–1500 ERK2 bins) for both stimuli. We also tested these
relationships in cells treated for 1 h with or without the ERK
inhibitor (FR180204) before stimulation with EGF (i.e. by bin-
ning the data shown as population averages in Fig. 3, E and F)
and found that the inhibitor had similar effects to the K52R
ERK2 mutation (compare Fig. 7, G and H with E and F). Most
FIGURE 6. ppERK2 activation developsmore rapidly at low ERK2 levels in
HeLaandMCF7 cells.HeLa cells (panels A–D) orMCF7 cells (panels E–H) were
treated as described under Fig. 5, with 10 nM EGF (A, B, E, and F) or 1M PDBu
(C, D, G, and H) as indicated, except that the stimulus was for 0–14 min. After
imaging, individual cellswerebinned for calculationofmeanppERK2 level for
the indicatedERK2-GFPbins (values inAFU). The left panels showppERK levels
normalized to the maximum level with the appropriate stimulus irrespective
of ERK2-GFP bin, whereas in the right panels levels were normalized to the
maximumppERK level in anygivenERK2-GFPbin, to emphasizedifferences in
amplitude and kinetics, respectively. The legends in the left hand panels also
apply to the corresponding right hand panel and the data shown are pooled
from 3 separate experiments (mean S.E., n 3).
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importantly, the fact that the switch occurred in K52R ERK2-
expressing cells (Fig. 7, E and F) and in the presence of the ERK
inhibitor (Fig. 7, G and H) implies that this time-dependent
change in the relationship betweenERKandppERK levels is not
due to ERK-mediated negative feedback.
DISCUSSION
Many extracellular signals act via the Raf/MEK/ERK cascade
in which response amplitude, kinetics, cell-cell variability, sen-
sitivity, and system robustness are fundamental attributes that
determine effects of ERK on cell fate. The system is subject to
several forms of negative regulation with different mechanisms
and time scales (Fig. 8). Such feedback is important for control
of cell fate, but most work in this field focuses on chronic (long
term) stimulation, with much less known about acute stimula-
tion. A principal aim of this study was to determine how ERK-
mediated feedback shapes ERK signaling in cells acutely stim-
ulatedwith EGF (ErbB1 activation) and PDBu (PKCactivation).
We used a HeLa cell model in which these stimuli cause more-
or-less transient, activating phosphorylation and nuclear trans-
location of ERK (Fig. 1) and were particularly interested in the
role that ERK-mediated feedback plays in the non-equilibrium
conditions of acute stimulation. Our data reveal a system in
which ERK-mediated negative feedback has major effects in
unstimulated cells and that such effects are less evident with
short term activation and then recover with continued
stimulation.
By expressing catalytically inactive K52R ERK2 (as a GFP
fusion) or by chemically inhibiting ERK, we found in unstimu-
lated cells that ERK-mediated negative feedback reduces not
only population-averaged ppERK2 levels (Figs. 2 and 3) but also
variability in ppERK2 levels across cells (Fig. 2) as well as
increasing system robustness to changes in total ERK levels
(Fig. 2). Similarly, in acutely stimulated cells, ERK-mediated
negative feedback contributes to the reduction in average
ppERK levels and the associated reduction in the variability
(CVs) of ppERK that occurs between 5 min and 4 h (Fig. 3).
Interestingly, ERK-mediated negative feedback rapidly (within
10 min) influenced population-averaged ppERK levels (Fig. 3),
but this rapid (transcription-independent) effect was not asso-
ciated with reduced cell-cell variability in the same timeframe
(not shown). Moreover, concentration-response curves for
EGF and PDBu effects on ppERK (population average
responses) at 5 min and 4 h (Fig. 1) had indistinguishable Hill
coefficients, arguing against a change in sensitivity of mean
ppERK levels to input intensity as a result of negative feedback.
Thus, in stimulated cells we saw relatively rapid ERK-mediated
feedback effects on ppERK levels (within 10 min, Fig. 3), slower
effects on ppERKvariability (within 4 h, see the legend to Fig. 3),
and no effect on response sensitivity (within 4 h, Fig. 1). These
findings are summarized in Fig. 8).
We found no evidence for negative feedback influencing
whether the ppERK response shows graded or all-or-nothing
behavior at the population-average level. Furthermore, fre-
quency-distribution curves for populations of single cells (Fig.
4) consistently revealed unimodal responses irrespective of the
type and concentration of stimulus used, the stimulus duration,
the response measured (ppERK levels, nuclear accumulation of
ERK, ERK-driven transcription), and whether or not ERK-me-
diated feedback was permitted (data not shown). A recent
report (37) attributed the bimodal ppERK responses seen in
EGF-stimulated HEK293 cells to cell-cell variability in Ras acti-
vation and pathway design that incorporates negative feedback
FIGURE 7. Dependence of ppERK response kinetics on ERK level can be
mathematically modeled assuming distributive (but not processive)
activation and occurs at a wide range of EGF concentrations and is not
dependent on ERK-mediated feedback. Panels A and B, shown are whole
cell ppERK levels, as predicted by mathematical modeling of ERK activation
assuming either processive (A) or distributive (B) dual phosphorylation of ERK
(models are described in the supplemental data). In each case ERK concentra-
tion was set at low, intermediate, or high using arbitrary values of 750, 1000,
and1250AFU, respectively (as indicated). Experimental data (EGF stimulation
at 750–1000AFUERK2-GFP) are superimposed inpanel B (open circles). Panels
C andD, cells transfectedwith siRNA targeting ERK and then transducedwith
Ad ERK2-GFP before stimulation for 2 or 12 min with EGF as shown. Mean
ppERK2 values are plotted against ERK2-GFP bin center (mean S.E., n 3,
the legend in C applies also to D). Panels E and F, cells were transfected with
siRNA targeting ERK and then transduced with Ad ERK2-GFP or K52R ERK2-
GFPbefore stimulation for 0or 2–14minwith 10nMEGF.MeanppERK2values
are shown against time for the indicated ERK2-GFP bin centers (mean S.E.,
n 3, legend in F applies also to E) and normalized (norm.) to the maximum
ppERK level in any given ERK2-GFP bin. Panels G andH, cells were transfected
with siRNA targeting ERK, transduced with Ad ERK2-GFP, and pretreated for
24 hwith 0 (Ctrl.) or 30MFR180204before stimulation for 0 or 2–14minwith
10 nM EGF. Mean ppERK2 values are shown against time for the indicated
ERK2-GFP bin centers (mean S.E., n 3, legend in H applies also to G) and
normalized (norm.) to the maximum ppERK level in any given ERK2-GFP bin.
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rather than to response ultrasensitivity or bistability as often
assumed. In this regard it is of interest that we saw only uni-
modal ppERK responses when ERK expression variability was
increased (by varying Ad ERK2 titer). Thus although negative
feedback and/or cell-cell variability in protein levels have the
potential to influence whether ppERK responses are all-or-
nothing at the single cell level and hence bimodal, we saw no
bimodality in theHeLa cell system used here (as summarized in
Fig. 8).
As noted above, the time-dependent reduction in ppERK2
levels was lower in cells expressing K52R ERK2 (than in cells
with ERK2), but the desensitization was not completely pre-
vented by the mutation. This implies that additional mecha-
nisms contribute to the observed adaptation (Fig. 3), and stim-
ulus-induced, down-regulation of ErbB1 (36) likely contributes
to desensitization of the EGF effect. Indeed, mathematical
modeling has revealed receptor internalization as a major
determinant of EGF signal termination (38), and this is consis-
tent with our observed reduction in EGF efficacy and potency
that occurs between 5 min and 4 h (Fig. 1). This clearly influ-
ences input-output behavior, so it is worth stressing that our
observation that there is no reduction in response sensitivity
between 5 min and 4 h is based on the lack of measurable
change in Hill coefficient with either stimulus (Fig. 1).
We also used cell binning to define relationships between
levels of total ERK and ppERK (i.e. to explore “concentration
robustness” of the signaling system (39)). Our work is related to
a previous study (16) where ERK expression was manipulated
with inhibitory RNAs targeting ERK1 and/or ERK2, and it was
found that ERK-mediated negative feedback increased robust-
ness to total ERK, converting a linear relationship between ERK
and ppERK levels to a hyperbolic one. In contrast to this work,
we focused on the behavior under acute stimulation (as
opposed to chronic activation by mutation of Ras or Raf). Our
FIGURE 8. Summary of system architecture andmain findings. Panel A illustrates the ERK cascade with a tyrosine kinase receptor (TKR) acting via adapters
andeffectors (Grb, SOS) to stimulate Ras (H-Ras, K-Ras, orN-Ras). Ras then activates Raf (A-Raf, B-Raf, or C-Raf) causing activatingphosphorylationofMEK (MEK1
orMEK2) that in turn catalyzes dual phosphorylation of ERK (ERK1 or -2). Alternativemechanisms include activation of Raf by PKC (dotted arrow). Transcription-
independent and transcription-dependent (dual specificity phosphatase-mediated) negative feedback pathways are also shown as are upstream receptor-
specific feedback mechanisms (curved dotted line). Our most important finding is that the ERK expression level influences ppERK response kinetics as well as
amplitude (panel B) such that maximal activation initially occurs at the submaximal ERK level and then switches to an increasing monotonic relationship
(maximal activation atmaximal ERK level)within 12min for eachof the cell lines studied. This is apparently not-dependentonERK-mediatednegative feedback
(as it is evident in cells expressing catalytically inactive ERK2) and could bemodeled assuming distributive activation as illustrated by the schematic in panel C.
Also illustrated (lower panels) are some of the system features potentially regulated by negative (-ve) feedback (FB). These include population-averaged
response kinetics (D), the relationship between stimulus concentration (E) or ERK concentration (F) and system output, cell-cell variability in ppERK levels (G),
and bimodality as opposed to unimodality of ppERK distributions (H). In our HeLa cell model, ERK-mediated negative feedback shapes population-averaged
ppERK responses (within 10min in EGF-stimulated cells as well as between 5min and 4 h for EGF and PDBu-stimulated cells) (check inD). It does not influence
systemsensitivity to EGFor PDBu concentration (cross in E) but does provide robustness to changes in ERK level in unstimulated cells (check in F). It also reduces
cell-cell variability in ppERK levels in unstimulated cells (check in G) but does not convert a bimodal distribution to a unimodal one (cross in panel H). Bimodal
distributions were not seen for any of the conditions used or end-points measured.
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data revealed a complex and initially surprising relationship.
For both stimuli the relationship between ERK and ppERK lev-
els was bell-shaped at 5 min and approximately hyperbolic at
later time points (Fig. 5). To explore further, we focused on
early time points (0–14 min), and again, the responses to both
stimuli were slower at higher ERK levels, as revealed by the
longer time taken to achieve the half-maximal ppERK response
(Fig. 6). The switch frombell-shaped ERK2-ppERK2 input-out-
put behavior at 2 or 4 min to increasing monotonic relation-
ships at 12 min was again observed (Fig. 6). Importantly, this
behavior was not restricted to HeLa cells as ppERK response
amplitude and kinetics were also dependent on ERK expression
levels in MCF7 (breast cancer) cells (Fig. 6). Despite inevitable
quantitative differences between responses in these cells, the
novel and unexpected observation of a switch from an initial
bell-shaped ERK2-ppERK2 relationship at 2–4 min to an
increasing monotonic one at 12 min was made with both cell
lines tested (Fig. 6).
Our key observationwas thatmaximal ERK activation occurs
initially at a submaximal ERK concentration, but the mecha-
nisms underlying this effect remain unclear.When ERK activa-
tion is distributive, ERK binds to MEK and is then monophos-
phorylated and released before rebinding to facilitate the
second phosphorylation in the Thr-Glu-Tyr loop. Conse-
quently, non-phosphorylated ERK may compete with mono-
phosphorylated ERK for binding to MEK and thereby inhibit
the second phosphorylation, which is needed for activation as
well as for detection by the ppERK antibodies used here (Fig. 8).
Such competition is consistent with the key observation above.
In early in vitro studies increasing ERK concentration actually
reduced ppERK concentration in kinase assays with semi-puri-
fiedMEK and ERK (24). The alternative scenario is that of pro-
cessive dual phosphorylation in which a substrate binds a
kinase and is dual-phosphorylated without release and rebind-
ing. Accordingly, we used a mathematical modeling approach
and found that our data could be accurately predicted by mod-
eling activation as distributive (but not as processive) (Fig. 7).
Distributive activation provides the simplest explanation for
our data (Fig. 8). However, a recent study concluded that ERK
activation is (pseudo)processive as a consequence of “molecular
crowding,” providing a possible explanation for the observed
graded responses in mammalian cells (26). By contrast, the
early mathematical modeling of distributive activation in the
absence of negative feedback predicted an ultrasensitive ppERK
response of the cascade itself, whereas we did not observe such
non-graded responses at any time point. Interestingly, our find-
ings of graded responses both in the presence and absence of
negative feedback are similar to those for the Fus3 response in
yeast (40). EGF concentration curves constructed at 5 min (Fig.
1, see also Ref. 26) had a Hill coefficient of 1 (demonstrating
sensitivity greater than expected for simple Michaelis-Menten
kinetics), but the Hill coefficient for PDBu was 1 under the
same conditions, suggesting that these measures reflect
upstream features rather than sensitivity of the Raf/MEK/ERK
cascade itself. It is also noteworthy that ERK stimulation is typ-
ically associatedwith translocation of theKSR scaffold from the
cytoplasm to plasmamembrane, raising the intriguing possibil-
ity that there could be a time-dependent shift from unscaf-
folded to scaffolded ERK activation (41) and an associated shift
from distributive to (pseudo)processive activation. To our
knowledge this scenario has not yet been modeled mathemati-
cally or tested experimentally. Finally, it is important to recog-
nize that more recent mathematical studies highlight the
potential for multisite phosphorylation to influence system
thresholdingwithout generating ultrasensitive behavior (42). In
the context of cell fate, this implies that Raf/MEK/ERK thresh-
olding could determine whether or not individual cells commit
to all-or-nothing fate decisions without, itself, dictating their
binary nature.
Another possible explanation for our data, but one we are
able essentially to rule out, is that overexpression of ERK in our
system might saturate KSR1 scaffolds (thereby causing distrib-
utive activation) in vivo. Published estimates of cellular ERK
concentrations range from 0.25 to 2.1 M in HeLa, PC12,
CHO, and COS-7 cells (43). However, our data reveal consid-
erable cell-cell variability with the mean concentration being
5-fold lower in the lowest 5 percentile than in the highest 5
percentile, suggesting that the majority of cells (95%) would
have endogenous ERKconcentrations between 0.12 and 4.7M.
The mean ERK2-GFP concentration is comparable to endoge-
nous ERK levels with the low Ad titer knockdown/add-back
protocol (29, 33), so we used this titer to determine ERK con-
centrations from the ERK2-GFPAFUmeasures, obtaining esti-
mates of 0.3, 0.8, 1.8, 2.8, 4.1, and 7.1 M (for the ERK2-GFP
bins used in Fig. 5). Thus, the vast majority of cells used for this
study (those in bins of up to 1500AFU) expressed ERK2-GFP at
concentrations found for endogenous ERK in commonly used
cell lines. Most importantly, the initial non-monotonic ERK2-
ppERK relationship occurs with physiologically relevant EGF
concentrations (36) andwithin the range of ERK2-GFP concen-
trations encountered with endogenous ERKs (Fig. 5).
Irrespective of the exact mechanisms, our data and the asso-
ciated mathematical modeling are suggestive of distributive
activation within the first 5 min of stimulation with EGF or
PDBu. The distributive activation model that most closely fits
our experimental data predicted that the switch from an initial
non-monotonic response (at 2 min) to a monotonic response
(by 12 min) would occur for a range of upstream input intensi-
ties (modeled as variedMEK activity), and consistent with this,
we found that the switch occurs at a broad range of EGF con-
centrations (Fig. 7). Importantly, the distributive activation
model does not include ERK-mediated negative feedback, sowe
also tested this using catalytically inactive ERK and by ERK
inhibition. This revealed that the initial maximal activation of
ERK at the submaximal ERK expression level also occurred in
cells expressing the K52R mutant and in cells treated with
FR180204 (Fig. 7). These data clearly argue that the switch is
not dependent upon ERK-mediated negative feedback despite
the fact that such feedback does occur in this time frame (Fig.
3). It is also not dependent upon upstream ErbB1-specific neg-
ative feedback, as it is also seen with ErbB1-independent ERK
activation by PDBu in both cell lines (Figs. 5 and 6).
An intriguing aspect of the observed change in the relation-
ship between ERK and ppERK levels is that it provides the
potential for the control or “gating” of the response by the inter-
play of the ERK expression level and the stimulus duration. For
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example, in ourHeLa cell system, a 2-min stimulationwith EGF
caused little or no ERK phosphorylation at the highest ERK
expression levels (1500–2500 AFU) and more pronounced
phosphorylation at lower levels (250–500 AFU) (Fig. 5). The
opposite is truewith a 14-min stimulation, where the amount of
ppERK positively correlates with ERK expression level. Simi-
larly, at intermediate ERK levels (750–1000 AFU), 2- and
14-min stimulations, both, result in less phosphorylation com-
pared with that obtained during the intervening time points.
Here, it should be noted that although much work on ERK
signaling explores equilibrium situations approached with
chronic stimulation (i.e. long term exposure to serum, growth
factors, or activating mutations), non-equilibrium activation is
very likely to be important physiologically. Examples include
smooth muscle cells where intrinsic Ca2	 oscillations have the
potential to drive ERKactivation (44, 45) or the neuroendocrine
system where hormones acting via G-protein-coupled recep-
tors to activate ERK are secreted in brief pulses. Gonadotropin-
releasing hormone (GnRH), for example, can be secreted in
pulses of a few minutes duration at intervals of 30–120 min.
Each GnRH pulse drives a pulse of PKC-mediated ERK activa-
tion, and GnRH receptor-mediated ERK activation is essential
for central control of reproduction (46, 47). The data shown
here suggest that the concentration of ERK in the target cells
could determine whether or not they respond to a GnRH pulse
and could also influence the rate of response termination after
stimulus removal. Cells expressing a high level of ERKwould be
expected not to have time to respond appreciably before the
pulse terminates, providing a mechanism for gating of the
response by the level of ERK. In this scenario, cell-cell variation
in the level of ERK expression could dictate the proportion of
cells responding to pulsatile GnRH stimulation, a feature
thought to be important for GnRH signaling (48, 49). Thus,
although we are not currently aware of specific physiological
scenarios in which ErbB1 occupancy changes rapidly, a surpris-
ing prediction of our work is that increasing ERK levels could
actually reduce ERK activation under physiologically relevant
stimulus durations for some stimuli.
In summary, we have used automated cell imaging to explore
the role of ERK-mediated negative feedback in shaping ERK
signaling inHeLa cells and have found clear evidence that ERK-
dependent feedback influences ppERK response kinetics, vari-
ability, and robustness in unstimulated cells just as it does in
chronically stimulated cells (Fig. 8). In acutely stimulated cells,
we observed reduction by ERK-mediated negative feedback of
average ppERK levels and cell-cell variation in these levels but
did not see any effect of negative feedback on the sensitivity of
ERK activation to stimulus concentration. When we consid-
ered robustness of the signaling system, we saw an unexpected,
bell-shaped relationship between total ERKandppERK levels at
2–5 min that switched to an increasing monotonic one within
12 min of stimulation. This novel behavior occurred in two cell
types (HeLa and MCF7 cells) in the presence and absence of
negative feedback and was predicted by mathematical models
incorporating distributive activation in acutely stimulated cells
but not by those with processive activation. The rapid switch
makes response kinetics dependent on ERK level and provides a
gating mechanism by which variation in ERK expression influ-
ences ERK responses under acute stimulation.
REFERENCES
1. Widmann, C., Gibson, S., Jarpe,M. B., and Johnson, G. L. (1999)Mitogen-
activated protein kinase. Conservation of a three-kinase module from
yeast to human. Physiol. Rev. 79, 143–180
2. Raman, M., Chen,W., and Cobb, M. H. (2007) Differential regulation and
properties of MAPKs. Oncogene 26, 3100–3112
3. Kyriakis, J. M., and Avruch, J. (2012) Mammalian MAPK signal transduc-
tion pathways activated by stress and inflammation. a 10-year update.
Physiol. Rev. 92, 689–737
4. Marshall, C. J. (1995) Specificity of receptor tyrosine kinase signaling.
Transient versus sustained extracellular signal-regulated kinase activa-
tion. Cell 80, 179–185
5. Chen, R. H., Sarnecki, C., and Blenis, J. (1992) Nuclear localization and
regulation of erk- and rsk-encoded protein kinases. Mol. Cell. Biol. 12,
915–927
6. Lidke, D. S., Huang, F., Post, J. N., Rieger, B., Wilsbacher, J., Thomas, J. L.,
Pouysségur, J., Jovin, T. M., and Lenormand, P. (2010) ERK nuclear trans-
location is dimerization-independent but controlled by the rate of phos-
phorylation. J. Biol. Chem. 285, 3092–3102
7. Brunet, A., Roux, D., Lenormand, P., Dowd, S., Keyse, S., and Pouysségur,
J. (1999) Nuclear translocation of p42/p44 mitogen-activated protein ki-
nase is required for growth factor-induced gene expression and cell cycle
entry. EMBO J. 18, 664–674
8. Kolch, W. (2005) Coordinating ERK/MAPK signalling through scaffolds
and inhibitors. Nat. Rev. Mol. Cell Biol. 6, 827–837
9. Harding, A., Tian, T., Westbury, E., Frische, E., and Hancock, J. F. (2005)
Subcellular localization determines MAP kinase signal output. Curr. Biol.
CB 15, 869–873
10. Kholodenko, B.N., Hancock, J. F., andKolch,W. (2010) Signalling ballet in
space and time. Nat. Rev. Mol. Cell Biol. 11, 414–426
11. Santos, S. D., Verveer, P. J., and Bastiaens, P. I. (2007) Growth factor-
induced MAPK network topology shapes Erk response determining
PC-12 cell fate. Nat. Cell Biol. 9, 324–330
12. Bashor, C. J., Helman, N. C., Yan, S., and Lim, W. A. (2008) Using engi-
neered scaffold interactions to reshape MAP kinase pathway signaling
dynamics. Science 319, 1539–1543
13. Ebisuya, M., Kondoh, K., and Nishida, E. (2005) The duration, magnitude,
and compartmentalization of ERK MAP kinase activity. Mechanisms for
providing signaling specificity. J. Cell Sci. 118, 2997–3002
14. Shankaran, H., and Wiley, H. S. (2010) Oscillatory dynamics of the extra-
cellular signal-regulated kinase pathway. Curr. Opin. Genet. Dev. 20,
650–655
15. Alon, U. (2007) Network motifs. Theory and experimental approaches.
Nat. Rev. Genet. 8, 450–461
16. Fritsche-Guenther, R., Witzel, F., Sieber, A., Herr, R., Schmidt, N., Braun,
S., Brummer, T., Sers, C., and Blüthgen, N. (2011) Strong negative feed-
back from Erk to Raf confers robustness to MAPK signalling. Mol. Syst.
Biol. 7, 489
17. Markevich, N. I., Hoek, J. B., and Kholodenko, B. N. (2004) Signaling
switches and bistability arising from multisite phosphorylation in protein
kinase cascades. J. Cell Biol. 164, 353–359
18. Mackeigan, J. P.,Murphy, L.O., Dimitri, C. A., and Blenis, J. (2005)Graded
mitogen-activated protein kinase activity precedes switch-like c-Fos in-
duction in mammalian cells.Mol. Cell. Biol. 25, 4676–4682
19. Takahashi, S., and Pryciak, P.M. (2008)Membrane localization of scaffold
proteins promotes graded signaling in the yeast MAP kinase cascade.
Curr. Biol. CB 18, 1184–1191
20. Lin, J., Harding, A., Giurisato, E., and Shaw, A. S. (2009) KSR1 modulates
the sensitivity ofmitogen-activated protein kinase pathway activation inT
cells without altering fundamental system outputs. Mol. Cell. Biol. 29,
2082–2091
21. Sturm, O. E., Orton, R., Grindlay, J., Birtwistle, M., Vyshemirsky, V., Gil-
bert, D., Calder, M., Pitt, A., Kholodenko, B., and Kolch, W. (2010) The
mammalian MAPK/ERK pathway exhibits properties of a negative feed-
ERK Expression Level and Feedback Dictate Response Kinetics
JULY 19, 2013•VOLUME 288•NUMBER 29 JOURNAL OF BIOLOGICAL CHEMISTRY 21013
 at University of Bath on August 8, 2013http://www.jbc.org/Downloaded from 
back amplifier. Sci. Signal. 3, ra90
22. Malleshaiah, M. K., Shahrezaei, V., Swain, P. S., and Michnick, S. W.
(2010) The scaffold protein Ste5 directly controls a switch-like mating
decision in yeast. Nature 465, 101–105
23. Ferrell, J. E., Jr., and Machleder, E. M. (1998) The biochemical basis of an
all-or-none cell fate switch in Xenopus oocytes. Science 280, 895–898
24. Burack, W. R., and Sturgill, T. W. (1997) The activating dual phosphory-
lation of MAPK by MEK is nonprocessive. Biochemistry 36, 5929–5933
25. Takahashi, K., Tanase-Nicola, S., and tenWolde, P. R. (2010) Spatio-tem-
poral correlations can drastically change the response of a MAPK path-
way. Proc. Natl. Acad. Sci. U.S.A. 107, 2473–2478
26. Aoki, K., Yamada, M., Kunida, K., Yasuda, S., and Matsuda, M. (2011)
Processive phosphorylation of ERKMAP kinase inmammalian cells. Proc.
Natl. Acad. Sci. U.S.A. 108, 12675–12680
27. Caunt, C. J., Armstrong, S. P., Rivers, C. A., Norman, M. R., andMcArdle,
C. A. (2008) Spatiotemporal regulation of ERK2 by dual specificity phos-
phatases. J. Biol. Chem. 283, 26612–26623
28. Dimitri, C. A., Dowdle, W., MacKeigan, J. P., Blenis, J., and Murphy, L. O.
(2005) Spatially separate docking sites on ERK2 regulate distinct signaling
events in vivo. Curr. Biol. CB 15, 1319–1324
29. Caunt, C. J., and McArdle, C. A. (2010) Stimulus-induced uncoupling of
extracellular signal-regulated kinase phosphorylation from nuclear local-
ization is dependent on docking domain interactions. J. Cell Sci. 123,
4310–4320
30. Cohen, D. M., Gullans, S. R., and Chin, W. W. (1996) Urea inducibility of
egr-1 in murine inner medullary collecting duct cells is mediated by the
serum response element and adjacent Ets motifs. J. Biol. Chem. 271,
12903–12908
31. Caunt, C. J., Finch, A. R., Sedgley, K. R., Oakley, L., Luttrell, L. M., and
McArdle, C. A. (2006) Arrestin-mediated ERK activation by gonadotro-
pin-releasing hormone receptors. Receptor-specific activation mecha-
nisms and compartmentalization. J. Biol. Chem. 281, 2701–2710
32. Caunt, C. J., Armstrong, S. P., and McArdle, C. A. (2010) Using high-
content microscopy to study gonadotrophin-releasing hormone regula-
tion of ERK.Methods Mol. Biol. 661, 507–524
33. Caunt, C. J., Rivers, C. A., Conway-Campbell, B. L., Norman, M. R., and
McArdle, C. A. (2008) Epidermal growth factor receptor and protein ki-
nase C signaling to ERK2. Spatiotemporal regulation of ERK2 by dual
specificity phosphatases. J. Biol. Chem. 283, 6241–6252
34. Finch, A. R., Caunt, C. J., Perrett, R. M., Tsaneva-Atanasova, K., and
McArdle, C. A. (2012) Dual specificity phosphatases 10 and 16 are positive
regulators of EGF-stimulated ERK activity. Indirect regulation of ERK
signals by JNK/p38 selective MAPK phosphatases. Cell. Signal. 24,
1002–1011
35. Ohori, M., Kinoshita, T., Okubo, M., Sato, K., Yamazaki, A., Arakawa, H.,
Nishimura, S., Inamura, N., Nakajima, H., Neya, M., Miyake, H., and Fujii,
T. (2005) Identification of a selective ERK inhibitor and structural deter-
mination of the inhibitor-ERK2 complex. Biochem. Biophys. Res. Com-
mun. 336, 357–363
36. Aharonov, A., Pruss, R. M., and Herschman, H. R. (1978) Epidermal
growth factor. Relationship between receptor regulation and mitogenesis
in 3T3 cells. J. Biol. Chem. 253, 3970–3977
37. Birtwistle, M. R., Rauch, J., Kiyatkin, A., Aksamitiene, E., Dobrzyński, M.,
Hoek, J. B., Kolch, W., Ogunnaike, B. A., and Kholodenko, B. N. (2012)
Emergence of bimodal cell population responses from the interplay be-
tween analog single-cell signaling and protein expression noise.BMCSyst.
Biol. 6, 109
38. Schoeberl, B., Eichler-Jonsson, C., Gilles, E. D., and Müller, G. (2002)
Computational modeling of the dynamics of the MAP kinase cascade
activated by surface and internalized EGF receptors. Nat. Biotechnol. 20,
370–375
39. Alon, U., Surette, M. G., Barkai, N., and Leibler, S. (1999) Robustness in
bacterial chemotaxis. Nature 397, 168–171
40. Yu, R. C., Pesce, C. G., Colman-Lerner, A., Lok, L., Pincus, D., Serra, E.,
Holl,M., Benjamin, K., Gordon, A., andBrent, R. (2008)Negative feedback
that improves information transmission in yeast signalling. Nature 456,
755–761
41. Ory, S., Zhou, M., Conrads, T. P., Veenstra, T. D., and Morrison, D. K.
(2003) Protein phosphatase 2A positively regulates Ras signaling by de-
phosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Curr.
Biol. CB 13, 1356–1364
42. Gunawardena, J. (2005) Multisite protein phosphorylation makes a good
threshold but can be a poor switch. Proc. Natl. Acad. Sci. U.S.A. 102,
14617–14622
43. Fujioka, A., Terai, K., Itoh, R. E., Aoki, K., Nakamura, T., Kuroda, S.,
Nishida, E., and Matsuda, M. (2006) Dynamics of the Ras/ERK MAPK
cascade as monitored by fluorescent probes. J. Biol. Chem. 281,
8917–8926
44. Walker, S. A., Cullen, P. J., Taylor, J. A., and Lockyer, P. J. (2003) Control of
Ras cycling by Ca2	. FEBS Lett. 546, 6–10
45. Kupzig, S., Walker, S. A., and Cullen, P. J. (2005) The frequencies of cal-
cium oscillations are optimized for efficient calcium-mediated activation
of Ras and the ERK/MAPK cascade. Proc. Natl. Acad. Sci. U.S.A. 102,
7577–7582
46. Armstrong, S. P., Caunt, C. J., Fowkes, R. C., Tsaneva-Atanasova, K., and
McArdle, C. A. (2010) Pulsatile and sustained gonadotropin-releasing
hormone (GnRH) receptor signaling. Does the ERK signaling pathway
decode GnRH pulse frequency? J. Biol. Chem. 285, 24360–24371
47. Caunt, C. J., Finch, A. R., Sedgley, K. R., and McArdle, C. A. (2006) GnRH
receptor signalling to ERK. Kinetics and compartmentalization. Trends
Endocrinol. Metab. TEM 17, 308–313
48. Ruf, F., Park, M. J., Hayot, F., Lin, G., Roysam, B., Ge, Y., and Sealfon, S. C.
(2006)Mixed analog/digital gonadotrope biosynthetic response to gonad-
otropin-releasing hormone. J. Biol. Chem. 281, 30967–30978
49. Ruf, F., Hayot, F., Park, M. J., Ge, Y., Lin, G., Roysam, B., and Sealfon, S. C.
(2007) Noise propagation and scaling in regulation of gonadotrope bio-
synthesis. Biophys. J. 93, 4474–4480
ERK Expression Level and Feedback Dictate Response Kinetics
21014 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 288•NUMBER 29•JULY 19, 2013
 at University of Bath on August 8, 2013http://www.jbc.org/Downloaded from 
